Simultaneous intravitreal and intracameral injection of bevacizumab (Avastin) in neovascular glaucoma

Journal of Ocular Pharmacology and Therapeutics

Volumn 25, Issue 3, 2009, Pages 259-263

  Yuzbasioglu, Erdal ^a,b   Artunay, Ozgur ^a   Rasier, Rifat ^a   Sengul, Alper ^a   Bahcecioglu, Halil ^a  

^a ISTANBUL BILIM UNIVERSITY   (Turkey)

^b Levent Konaklar Mahallesi Sogut Sok   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB;

ADULT; AGED; ARTICLE; CENTRAL RETINA VEIN OCCLUSION; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE SEVERITY; EYE SURGERY; FEMALE; HUMAN; INTRAOCULAR PRESSURE; IRIS NEOVASCULARIZATION; MALE; NEOVASCULAR GLAUCOMA; NEOVASCULARIZATION (PATHOLOGY); TREATMENT OUTCOME; VITREOUS BODY;

AGED; ANGIOGENESIS INHIBITORS; ANTERIOR CHAMBER; ANTIBODIES, MONOCLONAL; DIABETIC RETINOPATHY; DRUG ADMINISTRATION ROUTES; FEMALE; FLUORESCEIN ANGIOGRAPHY; GLAUCOMA, NEOVASCULAR; HUMANS; INJECTIONS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; RETINAL VEIN OCCLUSION; RETROSPECTIVE STUDIES; VITREOUS BODY;

EID: 66249099523     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2008.0088     Document Type: Article

References (18)

1. Mason, J.O., Albert, M.A., Mays, A., et al. Regression of neovascular iris vessels by intravitreal injection of bevacizumab. Retina. 26:839-841, 2006.
2. Avery, R.L. Regression of retinal and iris neovascularization after intravitreal bevacizumab (Avastin) treatment. Retina. 26:352-354, 2006.
3. Rosenfeld, P.J., Moshfeghi, A.A., and Puliaf to, C.A. Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmic. Surg. Lasers Imaging 36:331-335, 2005.
4. Rich, R.M., Rosenfeld, P.J., Puliaf to, C.A., et al. Short term safety and eff cacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Retina. 26: 495-511, 2006.
5. Spaide, R.F., Laud, K., Fine, H.F., et al. Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration. Retina. 26:383-390, 2006.
6. Rosenfeld, P.J., Fung, E.A., and Puliaf to, C.A. Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for macular edema from central retinal vein occlusion. Ophthalmic. Surg. Lasers Imaging 36:336-339, 2005.
7. Ituralde, D., Spaide, R.F., Meyerle, C.B., et al. Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study. Retina. 26:279-284, 2006.
8. Spaide, R.F., and Fisher, Y.L. Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage. Retina. 26:275-278, 2006.
9. Parodi, M.B., Friberg, T.R., Pedio, M., et al. Panretinal photocoagulation and photodynamic therapy for anterior segment neovascularization to ischemic central retinal vein occlusion. Ophthalmic. Surg. Lasers Imaging 38:94-99, 2007.
10. Boyd, S.R., Zachary, I., Chackravarthy, U., et al. Correlation of increased vascular endothelial growth factor with neovascularization and permeability in ischemic central vein occlusion. Arch. Ophthalmol. 120:1644-1650, 2002.
11. Tripathi, R.C., Li, J., Tripahti, B.J., et al. Increased level of vascular endothelial growth factor in aqueous humor of patients with neovascular glaucoma. Ophthalmology. 105:232-237, 1998.
12. Malik, R.A., LI, C., Aziz, W., et al. Elevated plasma CD 105 and vitreous VEGF levels in diabetic retinopathy. J. Cell Med. 9:692-697, 2005.
13. Kahook, M.Y., Schuman, J.S., and Noecker, R.J. Intravitreal bevacizumab in a patient with neovascular glaucoma. Ophthalmic. Surg. Lasers Imaging 37:144-146, 2006.
14. Davidorf, F.H., Mouser, J.G., and Derick, R.J. Rapid improvement of rubeosis iridis from a single bevacizumab (Avastin) injection. Retina. 26:354-356, 2006.
15. Vatavuk, Z., Bencic, G., and Mandic, Z. Intravitreal bevacizumab for neovascular glaucoma following central retinal artery occlusion. Eur. J. Ophthalmol. 17:269-271, 2007.
16. Iliev, M.E., Domig, D., Wolf-Schnurbursch, U., et al. Intravitral bevacizumab (Avastin) in the treatment of neovascular glaucoma. Am. J. Ophthalmol. 142:1054-1056, 2006.
17. Batioglu, F., Atsam, N., and Özmert, E. Rapid improvement of retinal and iris neovascularization after a single intravitreal bevacizumab injection in a patient with central retinal vein occlusion and neovascular glaucoma. Int. Ophthalmol. 28(1):59-61, 2008.
18. Grisanti, S., Biester, S., Peters, S., et al. Intracameral bevacizumab for iris rubeosis. Am. J. Ophthalmol. 142:158-160, 2006.